BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30058687)

  • 1. MiR-431 inhibits cell proliferation and induces cell apoptosis by targeting CDK14 in pancreatic cancer.
    Yang J; Zhu H; Jin Y; Song Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4493-4499. PubMed ID: 30058687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-455 inhibits breast cancer cell proliferation through targeting CDK14.
    Wang B; Zou A; Ma L; Chen X; Wang L; Zeng X; Tan T
    Eur J Pharmacol; 2017 Jul; 807():138-143. PubMed ID: 28300591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14.
    Li Q; Zhou L; Wang M; Wang N; Li C; Wang J; Qi L
    Biomed Pharmacother; 2018 Feb; 98():636-642. PubMed ID: 29289838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.
    Sun Y; Wang P; Yang W; Shan Y; Zhang Q; Wu H
    Cancer Biol Ther; 2019; 20(6):729-739. PubMed ID: 30915884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
    Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
    Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK14/β-catenin/TCF4/miR-26b positive feedback regulation modulating pancreatic cancer cell phenotypes in vitro and tumor growth in mice model in vivo.
    Sun Y; Wang P; Zhang Q; Wu H
    J Gene Med; 2022 Feb; 24(2):e3343. PubMed ID: 33871149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression.
    Sun FB; Lin Y; Li SJ; Gao J; Han B; Zhang CS
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8640-8648. PubMed ID: 30575904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of miR-132 on proliferation and apoptosis of pancreatic cancer cells via Hedgehog signaling pathway.
    Zhao DW; Hou YS; Sun FB; Han B; Li SJ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1978-1985. PubMed ID: 30915740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
    Lin XM; Chen H; Zhan XL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
    Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
    Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-217 functions as a prognosis predictor and inhibits pancreatic cancer cell proliferation and invasion via targeting E2F3.
    Yang J; Zhang HF; Qin CF
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4050-4057. PubMed ID: 29028097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
    Yan TH; Qiu C; Sun J; Li WH
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
    Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
    Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer.
    Li S; Li X; Xing X; Wang L
    Hum Cell; 2020 Oct; 33(4):1165-1175. PubMed ID: 32613573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miR-489 in the proliferation and apoptosis of pancreatic carcinoma.
    Zeng M; Zhou Y; Zhang Y; Wang T; Wang J
    J BUON; 2019; 24(4):1574-1580. PubMed ID: 31646811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A.
    Shang C; Hong Y; Guo Y; Liu YH; Xue YX
    Med Sci Monit; 2014 Dec; 20():2571-7. PubMed ID: 25481483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3.
    Zhao G; Zhang JG; Shi Y; Qin Q; Liu Y; Wang B; Tian K; Deng SC; Li X; Zhu S; Gong Q; Niu Y; Wang CY
    PLoS One; 2013; 8(9):e73803. PubMed ID: 24040078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.
    Zhang P; Guo Z; Hu R; He X; Jiao X; Zhu X
    Tumour Biol; 2015 Dec; 36(12):9693-701. PubMed ID: 26152285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.